Latest Breaking News On - Huseyin naci - Page 2 : comparemela.com

Costs of expensive new drugs threaten financial sustainability of NHS while pharma industry lobbies for increase on medicines spending

Since 2018 NHS spending on branded medicines has been increasing by over five per cent annually.

United kingdomJames lomasHuseyin naciAris angelisSenior researchProfessor of healthProfessor of health economicsUniversity of yorkRegulatory agencyLondon school of hygiene tropical medicineLondon schoolTropical medicineAssociate professorHealth policyVoluntary schemeBranded medicines pricing

Medicare Spending Millions on Cancer Drugs With Unproven Benefit

Cancer drug indications with accelerated approvals that have not been shown to improve survival are costing millions. Top policy experts suggest prices should be cut.

United statesUnited kingdomWhite houseDistrict of columbiaMichael chernewEzekiel emanuelHanita wagnerRichard frankMahnum shahzadPaul ginsburgHuseyin naciCenters for medicare medicaid servicesLondon school of economicsHuman servicesResearch letterDrug administration

More Follow Up Needed for Drugs Granted Accelerated FDA Approval

Drugs to treat serious or life-threatening conditions can receive accelerated FDA approval, but may expose patients to increased safety risks and reduced efficacy

Huseyin naciLondon school of economicsDrug administrationLondon schoolPolitical scienceAccelerated approvalOnfirmatory studiesDrug safetySurrogate measures

Targeted News Service

Targeted News Service
targetednews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from targetednews.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofHuseyin naciUniversity of londonLondon school of economicsCurrent standardsDrug regulationShould be improvedPolitical scienceBritish medical journalஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்பல்கலைக்கழகம் ஆஃப் லண்டன்லண்டன் பள்ளி ஆஃப் பொருளாதாரம்மருந்து ஒழுங்குமுறைபொலிடிகல் அறிவியல்

BMJ: FDA Allows Drugs Without Proven Clinical Benefit to Languish for Years

BMJ: FDA Allows Drugs Without Proven Clinical Benefit to Languish for Years
laboratoryequipment.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laboratoryequipment.com Daily Mail and Mail on Sunday newspapers.

Elisabeth mahaseCelecoxib celebrexRachel sachsHuseyin naciWashington universityInstitute for clinicalLondon school of economicsDrug administrationUs government accountability officeDrugs without proven clinical benefitLondon schoolAccountability officeEconomic reviewரேச்சல் சாக்ஸ்வாஷிங்டன் பல்கலைக்கழகம்நிறுவனம் க்கு மருத்துவ